Advantages
Facility standards
The multiproduct facilities are designed to comply with NMPA, FDA, and EMA standards which have received Chinese GMP certificates and have been audited/inspected by global biopharmaceutical companies and regulatory agencies.
High success rates of commercialization and technology transfer
Greater than 99% successful rate to ensure on-time delivery to meet client timelines.
Cost control
Good experience in lean operations management and commercialized cost control
Production team
Our team is fully staffed with highly experienced professionals with biopharmaceutical manufacturing and quality management experience.
Copyright@Altruist Biologics
Subscribe to our newsletter
Incorrect Email Format
Subscribe to our newsletter
Incorrect Email Format